Z.Sh. GARAYEVA¹, L.A. YUSUPOVА¹, G.I. MAVLYUTOVA¹, E.I. YUNUSOVА¹, M.A. FILATOVА²

¹Kazan State Medical Academy, 36 Butlerov St., Kazan, Russian Federation, 420012

²Republican Clinical Dermatovenereology Dispensary, 4 Tolstoy St., Kazan, Russian Federation, 420012

Garayeva Z.Sh. — Cand. Med. Sc., Associate Professor of the Department of Dermatology and Venereology and Cosmetology, tel. (843) 296-78-21, е-mail: garaeva-zuhra@rambler.ru

Yusupova L.A. — D. Med. Sc., Head of the Department of Dermatovenerology and Cosmetology, tel. +7-917-260-32-57, e-mail: yuluizadoc@hotmail.com

Mavlutova G.I. — Cand. Med. Sc., Associate Professor of the Department of Dermatology and Venereology and Cosmetology, tel. +7-927-249-11-68, е-mail: guzel.mavljutova@yandex.ru

Yunusova E.I. — Cand. Med. Sc., Associate Professor of the Department of Dermatology and Venereology and Cosmetology, tel. +7-919-635-28-61, е-mail: elenaiu@mail.ru

Filatova M.A. — dermatovenerologist of Policlinic Department № 2, tel. +7-927-402-08-50, е-mail: margosha.86@bk.ru

The article gives information about the limited scleroderma — a chronic connective tissue disease characterized by focal inflammatory and sclerotic changes in skin and underlying tissues without involvement of internal organs in the pathological process. The authors consider the issues of etiology and pathogenesis, classification, clinical differential diagnosis of the disease, as well as treatment methods. The features of mesotherapeutic method are described. We present a clinical example of a patient with plaque sclerosis complex therapy with mesotherapeutic intralesional injection.

Key words: limited scleroderma, etiopathogenesis, systemic and local therapy, mesotherapeutic methods

 

 

REFERENCES

1. Anan’eva L.P. Early systemic sclerosis – a modern diagnostic algorithm (lecture). Nauchno-prakticheskaya revmatologiya, 2012, no. 2, pp. 87-93 (in Russ.).

2. Volkov A.V., Guseva N.G. Systemic scleroderma in men. Nauchno-prakticheskaya revmatologiya, 2002, no. 2, p. 15 (in Russ.).

3. Alekperov R.T., Lyubimova E.G. Statins in systemic sclerosis. Meditsinskiy sovet, 2008, no. 5-6, pp. 57-60 (in Russ.).

4. Gallyamova Yu.A. Localized scleroderma. Lechashchiy vrach, 2008, no. 5, pp. 46-47 (in Russ.).

5. Guseva N.G. Systemic scleroderma – a multidisciplinary problem. Nauchno-prakticheskaya revmatologiya, 2011, no. 2, pp. 10-14 (in Russ.).

6. Yusupova L.A., Filatova M.A. Localized scleroderma: diagnosis, clinical features, treatment. Lechashchiy vrach, 2014, no. 5, pp. 51-55 (in Russ.).

7. Gurskiy G.E., Grebennikov V.A., Khoron’ko V.V. Modern conceptions of scleroderma. Klinicheskaya dermatologiya i venerologiya, 2012, vol. 10, no. 2, pp. 4-9 (in Russ.).

8. Kubanova A.A. Klinicheskie rekomendatsii. Dermatovenerologiya [Clinical guidelines. Dermatovenereology]. Moscow: DEKS-Press, 2010. 300 p.

9. Dvornikov A.S. Scleroderma is a disease associated with malignancy. Vestnik novykh meditsinskikh tekhnologiy, 2011, no. 2, pp. 419-420 (in Russ.).

10. Karateev A.E., Movsisyan M.M., Anan’eva L.P. et al. Pathology of the esophagus in systemic sclerosis: evidence of clinical and endoscopic examination. Nauchno-prakticheskaya revmatologiya, 2012, no. 1, pp. 54-59 (in Russ.).

11. Kurtas D.Sh., Molochkov A.V., Filatova E.V. Influence of the total infrared radiation for a limited scleroderma. Doktor.Ru., 2011, vol. 62, no. 3, pp. 60-64 (in Russ.).

12. Molochkov V.A., Snarskaya E.S., Romashkina A.S. Localized scleroderma associated with other diseases and autotimmunnymi range of different autoantibodies. Rossiyskiy zhurnal kozhnykh i venericheskikh bolezney, 2011, no. 4, pp. 33-36 (in Russ.).

13. Nasonova E.L. Revmatologiya: Klinichkskie rekomendatsii [Rheumatology: Klinichkskie recommendations]. Moscow: GEOTAR-Media, 2011. 752 p.

14. Dvornikov A.S. Therapy of patients with localized scleroderma drug hyaluronidase. Vestnik dermatologii i venerologii, 2013, no. 3, pp. 96-100 (in Russ.).

15. Mach E.S., Alekperov R.T., Burtseva E.A. et al. Angiology Modern trends in systemic sclerosis. Meditsinskaya vizualizatsiya, 2008, no. 6, pp. 107-113 (in Russ.).

16. Potekaev N.N., Vavilov V.V. The pathogenesis of scleroderma: current understanding. Klinicheskaya dermatologiya i venerologiya, 2012, vol. 10, no. 5, pp. 8-15 (in Russ.).

17. Polikarpova N.V., Kaleda S.P. Effect of hormone replacement therapy on the synthesis of endogenous hormones in systemic sclerosis with a primary lesion of the gastrointestinal tract. Vrach-aspirant, 2013, no. 6, pp. 193-198 (in Russ.).

18. Clements P.J., Furst D.E., Wong W.K. et al. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial. Arthritis Rheum., 1999, no. 42 (6), rr. 1194-1203.